Target intelligence / Profile preview

Periodontal pathogenic bacteria

Molecular classification
Bacteria, Gram-negative bacteria, Anaerobic bacteria, Other
01

Overview

Periodontal pathogenic bacteria are a specialized group of microorganisms, predominantly anaerobic and Gram-negative, that inhabit the subgingival biofilm and serve as the primary etiological agents of inflammatory periodontal diseases (StatPearls, 2023). The most significant pathogens include the "Red Complex"—Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola—which are strongly associated with advanced tissue destruction and clinical attachment loss (Socransky et al., 1998; NIH, 2023). These bacteria employ various virulence factors, such as proteases (gingipains) and lipopolysaccharides, to bypass host immune defenses and trigger a chronic inflammatory response that leads to the degradation of the periodontium and alveolar bone (Journal of Oral Microbiology, 2020). Furthermore, these pathogens are implicated in systemic health issues, including cardiovascular disease and diabetes, due to their ability to enter the bloodstream and promote systemic inflammation (American Academy of Periodontology, 2021). Therapeutic interventions aim to eradicate or suppress these populations using mechanical scaling and root planing often combined with antimicrobial agents like metronidazole, amoxicillin, or local-delivery doxycycline (Cochrane Database, 2020). These drugs work by inhibiting essential bacterial processes such as cell wall synthesis or protein translation, thereby reducing the bacterial burden and allowing for tissue healing.

Other names
PeriodontopathogensOral pathogenic bacteriaSubgingival microbiotaRed complex bacteriaPeriodontal pathogens
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, protein synthesis, or DNA replication; disruption of bacterial cell membrane and biofilm integrity

03

Biological functions

Biofilm formationProteolysisImmune evasionTissue degradationInflammatory signalingOther
04

Disease associations

PeriodontitisGingivitisCardiovascular diseaseDiabetes mellitusAlzheimer's diseaseInfectionInflammationOther
05

Safety considerations

Antimicrobial resistanceOral dysbiosis (disruption of commensal flora)Gastrointestinal distressHypersensitivity reactionsSystemic antibiotic toxicity
06

Interacting drugs

Amoxicillin

6 more in the full profile.

07

Biomarkers

Probing pocket depth (PPD)Bleeding on probing (BOP)Clinical attachment loss (CAL)Porphyromonas gingivalis DNA levelsGingival crevicular fluid (GCF) cytokine levels

Beyond the preview

Go deeper on Periodontal pathogenic bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periodontal pathogenic bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call